{{Rsnum
|rsid=17047586
|Gene=FAM19A1
|Chromosome=3
|position=68363724
|Orientation=plus
|GMAF=0.04775
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FAM19A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 64.7 | 33.1 | 2.2
| JPT | 73.5 | 26.5 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 64.7 | 33.1 | 2.2
| CHD | 67.9 | 30.3 | 1.8
| GIH | 89.1 | 10.9 | 0.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 96.8 | 3.2 | 0.0
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20664687
|Title=Single-nucleotide polymorphisms in chromosome 3p14.1- 3p14.2 are associated with susceptibility of type 2 diabetes with cataract
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}